Menu
Back to Journals » OncoTargets and Therapy » Volume 6
Original Research
Comparative study analyzing survival and safety of bevacizumab/carboplatin/paclitaxel and cisplatin/pemetrexed in chemotherapy-naïve patients with advanced non-squamous bronchogenic carcinoma not harboring EGFR mutation
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 10,221 | Dovepress* | 9,135+ | 1,863 | 10,998 | |
| PubMed Central* | 1,086 | 457 | 1,543 | ||
| Totals | 10,221 | 2,320 | 12,541 | ||
|
*Since 1 July 2013 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 3 | 1 | 0 | 0 | 0 | 2 |
View citations on PubMed Central and Google Scholar